Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.020
-0.147 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
3.010
-0.010 (-0.33%)
After-hours: Dec 5, 2025, 6:25 PM EST

Silexion Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2013 FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '13 Dec '12
Cash & Equivalents
9.241.194.60.791.6
Cash & Short-Term Investments
9.241.194.60.791.6
Cash Growth
101.15%-74.17%483.12%-50.69%-
Other Receivables
---0.090.16
Receivables
---0.090.16
Prepaid Expenses
1.740.970.340.01-
Restricted Cash
0.030.040.03--
Other Current Assets
0.050.060.020.040.03
Total Current Assets
11.062.254.980.931.79
Property, Plant & Equipment
0.470.560.250.010.01
Other Long-Term Assets
0.090.050.03--
Total Assets
11.612.865.260.941.8
Accounts Payable
0.950.930.320.10.08
Accrued Expenses
1.671.431.570.140.09
Short-Term Debt
-1---
Current Portion of Leases
0.170.160.11--
Other Current Liabilities
-00.2--
Total Current Liabilities
2.793.522.20.240.17
Long-Term Debt
1.542.96---
Long-Term Leases
0.310.370.06--
Total Liabilities
4.646.852.260.240.17
Common Stock
0.040---
Additional Paid-In Capital
57.6939.2611.345.164.74
Retained Earnings
-50.75-43.25-26.81-4.47-3.11
Total Common Equity
6.98-3.99-15.480.71.63
Minority Interest
--3.42--
Shareholders' Equity
6.98-3.9930.71.63
Total Liabilities & Equity
11.612.865.260.941.8
Total Debt
2.034.490.17--
Net Cash (Debt)
7.22-3.34.420.791.6
Net Cash Growth
63.16%-461.42%-50.69%-
Net Cash Per Share
12.67-79.44---
Filing Date Shares Outstanding
3.130.56---
Total Common Shares Outstanding
3.130.12---
Working Capital
8.27-1.272.780.691.62
Book Value Per Share
2.23-32.37---
Tangible Book Value
6.98-3.99-15.480.71.63
Tangible Book Value Per Share
2.23-32.37---
Machinery
-0.10.080.020.01
Leasehold Improvements
--0.06--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q